Anicteric leptospirosis-associated severe pulmonary hemorrhagic syndrome: a case series study

Stelios F Assimakopoulos1, Fotini Fligou, Markos Marangos

  • 1Department of Internal Medicine, University Hospital of Patras, Patras, Greece.

Insights

Severe pulmonary leptospirosis is a major cause of death. Early mechanical ventilation and hemodynamic support in farmers with acute respiratory distress syndrome reduced mortality, showing treatment effectiveness.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Critical Care Medicine

Background:

  • Leptospirosis is a zoonotic disease with severe pulmonary involvement, now a leading cause of mortality.
  • Severe pulmonary hemorrhagic syndrome (SPHS) has become the primary cause of death in leptospirosis cases.

Observation:

  • Four male farmers presented with acute respiratory distress syndrome (ARDS), fever, hemoptysis, pulmonary infiltrates, and thrombocytopenia.
  • Clinical presentation included anemia, renal failure, and elevated creatine kinase; only one patient had slightly increased bilirubin.
  • Serological diagnosis confirmed leptospirosis in all patients.

Findings:

  • Empirical ceftriaxone therapy was initiated immediately.
  • The ARDSNet protective mechanical ventilation strategy combined with early goal-directed hemodynamic management resulted in a 25% mortality rate.
  • Standard scoring systems (APACHE II, SAPS II, SOFA) failed to predict outcomes in these SPHS patients.

Implications:

  • This case series highlights the effectiveness of a combined therapeutic approach in managing severe pulmonary leptospirosis.
  • Early intervention with mechanical ventilation and hemodynamic support can significantly improve survival rates.
  • Current predictive scoring systems may not be adequate for assessing prognosis in leptospirosis-associated SPHS.